Codes / ICD10CM / M1A.1121

M1A.1121 Lead-induced chronic gout, left shoulder, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Left Shoulder, with Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis resulting from prolonged lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. This specific presentation affects the left shoulder and includes the presence of tophi, which are hard, nodular deposits of urate crystals. Untreated, it can lead to persistent joint damage and functional impairment.

Causes

This condition arises from chronic lead exposure, which impairs the kidneys' ability to excrete uric acid, leading to hyperuricemia and subsequent joint inflammation. Lead interferes with uric acid metabolism, promoting crystal formation. Exposure sources may include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults
  • Impaired kidney function

Symptoms

  • Recurrent intense joint pain in the left shoulder
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited shoulder mobility
  • Presence of visible or palpable tophi (nodular deposits)
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage, confirms left shoulder involvement, and identifies tophi. Clinical examination verifies the presence of tophaceous deposits.

Treatment Options

Treatment focuses on reducing lead exposure, managing uric acid levels, and alleviating symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs. Intra-articular injections or surgery may address tophi or severe joint damage. Lifestyle modifications, such as avoiding lead sources and dietary adjustments, support management.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular monitoring of uric acid levels and kidney function is essential. Untreated cases may progress to chronic joint deformity or disability. Follow-up care ensures adherence to therapy and early detection of complications.

Complications

  • Chronic joint damage or deformity
  • Persistent pain and functional impairment
  • Kidney stones or renal impairment from hyperuricemia
  • Infection of tophi if they ulcerate
  • Increased risk of acute gout flares

Lifestyle & Prevention

  • Avoid or minimize lead exposure (occupational or environmental)
  • Maintain a balanced diet low in purines
  • Stay hydrated to support uric acid excretion
  • Limit alcohol and sugary beverages
  • Follow prescribed medication regimens consistently

When to Seek Professional Help

Seek care if experiencing severe or worsening joint pain, swelling, or redness in the left shoulder. Prompt evaluation is needed if tophi appear, mobility decreases significantly, or symptoms interfere with daily activities. Immediate attention is required for signs of infection (e.g., fever, pus) or acute flare-ups.

Tips for Medical Coders

Document the left shoulder involvement and the presence of tophi (tophi) clearly in clinical notes. Ensure lead exposure history and chronic gout diagnosis are supported by lab results (e.g., elevated uric acid) or imaging. Code M1A.1121 is specific to left shoulder with tophi; verify laterality and tophus presence match the documentation.

Book a walkthrough

M1A.1121 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.